Cargando…
Synthesis and pharmacological characterization of ethylenediamine synthetic opioids in human μ‐opiate receptor 1 (OPRM1) expressing cells
Opioids are powerful analgesics acting via the human μ‐opiate receptor (hMOR). Opioid use is associated with adverse effects such as tolerance, addiction, respiratory depression, and constipation. Two synthetic opioids, AH‐7921 and U‐47700 that were developed in the 1970s but never marketed, have re...
Autores principales: | Hsu, Tom, Mallareddy, Jayapal R., Yoshida, Kayla, Bustamante, Vincent, Lee, Tim, Krstenansky, John L., Zambon, Alexander C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704399/ https://www.ncbi.nlm.nih.gov/pubmed/31463067 http://dx.doi.org/10.1002/prp2.511 |
Ejemplares similares
-
Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent
por: AL-Eitan, Laith N, et al.
Publicado: (2012) -
μ-Opioid receptor gene (OPRM1) polymorphism in patients with breast cancer
por: Cieślińska, Anna, et al.
Publicado: (2015) -
Identification of potential binding pocket on viral oncoprotein HPV16 E6: a promising anti-cancer target for small molecule drug discovery
por: Kolluru, Srikanth, et al.
Publicado: (2019) -
Human OPRM1 and murine Oprm1 promoter driven viral constructs for genetic access to μ-opioidergic cell types
por: Salimando, Gregory J., et al.
Publicado: (2023) -
Src‐dependent phosphorylation of μ‐opioid receptor at Tyr(336) modulates opiate withdrawal
por: Zhang, Lei, et al.
Publicado: (2017)